Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's disease

1 Jul 2025

Abstract excerpt

INTRODUCTION: Alzheimer's disease (AD) lacks a less invasive and early detectable biomarker. Here, we investigated the biomarker potential of miR-501-3p and miR-502-3p using different AD sources. METHODS: MiR-501-3p and miR-502-3p expressions were evaluated in AD cerebrospinal fluid (CSF) exosomes, serum exosomes, familial and sporadic AD fibroblasts and B-lymphocytes by qRT-PCR analysis. Further, miR-501-3p and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40629914
DOI: 10.1002/ctm2.70389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's diseasePMID 40629914Read ↗

miR-519a-3p, found to regulate cellular prion protein during Alzheimer’s disease pathogenesis, as a biomarker of asymptomatic stagesSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's diseaseSemantic proximity Read ↗

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s diseaseSemantic proximity Read ↗

Amyloid Beta and MicroRNAs in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseSemantic proximity Read ↗

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer diseaseSemantic proximity Read ↗

Role of MicroRNA-502-3p in Human DiseasesSemantic proximity Read ↗

miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stagesSemantic proximity Read ↗

A New Discovery of MicroRNA-455-3p in Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.